Teva Pharmaceutical Industries Ltd
Pharmaceutical Industries Ltd.
  • Teva Worldwide
  • Stock
  • Contact Us
  • Hebrew

See Teva's sites around the world

Americas

  • Canada
  • Curacao
  • United States

Growth Markets

  • Argentina
  • Australia
  • Belarus
  • Brazil
  • Chile
  • China
  • India
  • Israel
  • Kazakhstan
  • Mexico
  • Peru
  • Russia
  • Singapore
  • South Africa
  • Turkey
  • Ukraine
  • Uruguay
  • Uzbekistan

Japan & S. Korea

  • Japan
  • South Korea

Europe

  • Europe
  • Austria
  • Belgium
  • Bosnia & Herzegovina
  • Bulgaria
  • Croatia
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Macedonia
  • Monaco
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Serbia
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
See All See Less
Want to find out more about Teva's locations and phone numbers? Visit Teva Worldwide
Integrated Innovation that
Delivers Better Healthcare

For a Better Life

Teva Pharmaceutical Industries Ltd
  • About
    • About Lobby
    • Company Profile
    • Corporate Officers
    • Corporate Governance
    • Board of Directors
    • Our History
    2016 Annual Report on Form 20-F

    2016 Annual Report on Form 20-F

    Quality

    Quality

    Notice of Annual Meeting of Shareholders 2017 – Proxy Statement

    Notice of Annual Meeting of Shareholders 2017 – Proxy Statement

  • Products
    • Products Lobby
    • Specialty
    • Generic Products
    • Generic FAQ
    • Over the Counter (OTC)
    • API
    • Quality
    Central Nervous System (CNS)

    Central Nervous System (CNS)

    Respiratory

    Respiratory

  • Research
    • Research Lobby
    • Integrated R&D
    • Our Focus
    • Patient Promise
    • Pipeline
    • Business Development
    • Teva at IATI BIOMED 2015
    Leading the Fight for Cures

    Leading the Fight for Cures

    National Network of Excellence

    National Network of Excellence

  • Responsibility
    • Responsibility Lobby
    • Position on Antimicrobial Resistance (AMR)
    • 2016 Social Impact Report
    • Previous CSR Reports
    Supplier Code of Conduct & Information for Our Suppliers

    Supplier Code of Conduct & Information for Our Suppliers

    Global Patient Organization and Advocacy Disclosure

    Global Patient Organization and Advocacy Disclosure

  • Media
    • Media Lobby
    • Latest News
    • Featured Stories
    • Media Albums
    • Teva Fact Sheet
    • Teva Overview
    Four New Independent Directors Join the Teva Board

    Four New Independent Directors Join the Teva Board

  • Investors
    • Investors Lobby
    • News
    • Webcasts and Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Shareholder Information
    • Analysts Coverage/Consensus
    • Investor Kit
    • Contact Us
  • Careers
    • Careers Lobby
    • Our People
    • Grow with the Best
    • Our Guiding Values
    • Leadership Development
    Our People

    Our People

    Grow with the Best

    Grow with the Best

  • Teva Worldwide
  • Stock
  • Contact Us
  • Hebrew
  • Follow Us:
  • Home page
  • Research

Research

Uniquely Integrated Innovation

Bringing You New Treatments >
  • Specialty Medicines

    Specialty Medicines

  • Generic R&D

    Generic R&D

  • New Therapeutic Entities

    New Therapeutic Entities

Working to Make Life Better

Where We’re Making a Difference >

Central Nervous System (CNS)

We work tirelessly to transform knowledge into insights in the treatment of CNS diseases.
Discover more

Respiratory

Simple.
Intuitive.
Effective.
Discover more

Pipeline

View our treatments in development

With Outstanding Partners

 Collaborating. Sharing. Advancing >

Innovating Together

Think we’re a perfect match? Talk to us.

If you’ve got the right idea, we’ve got the right capabilities. Partner with us.

Discover more

The National Network of Excellence in Neuroscience (NNE)

Boosting therapeutic developments in key areas

Moving understanding forward in the discovery of new approaches.

Discover more

For You

Safe. Effective. Accessible >

Why We Do What We Do

Managing the impact of life-changing disease

Our Patient Promise

Every branch of our development process has the goal of improving patient outcomes at its heart. This is our promise.
Discover more
  • About
    • Company Profile
    • Corporate Officers
    • Corporate Governance
    • Board of Directors
    • Our History
  • Products
    • Specialty
    • Generic Products
    • Generic FAQ
    • Over the Counter (OTC)
    • API
    • Quality
  • Research
    • Integrated R&D
    • Our Focus
    • Patient Promise
    • Pipeline
    • Business Development
    • Teva at IATI BIOMED 2015
  • Responsibility
    • Position on Antimicrobial Resistance (AMR)
    • 2016 Social Impact Report
    • Previous CSR Reports
  • Media
    • Latest News
    • Featured Stories
    • Media Albums
    • Teva Fact Sheet
    • Teva Overview
  • Investors
    • News
    • Webcasts and Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Shareholder Information
    • Analysts Coverage/Consensus
    • Investor Kit
    • Contact Us
  • Careers
    • Our People
    • Grow with the Best
    • Our Guiding Values
    • Leadership Development
Teva Pharmaceutical Industries Ltd
  • Follow Teva:
  • Legal Notes
  • Data Privacy
  • TAPI
  • Supplier FAQs
  • Sitemap
  • © 2015 Teva Pharmaceutical Industries Ltd.